RVMDW
NASDAQ
$8.61
Revolution Medicines Inc - Warrants (17/12/2026) (RVMDW)
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops therapies to inhibit frontier targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
This company is also listed under the following ticker: RVMD.
Website: https://www.revmed.comBeta (5Y)
2.23
Price Chart
Profitability
Total Revenue (TTM)$742K
EBITDA-$1.03B
Growth & Risk
Beta (5Y)2.23
Sharpe Ratio2.35